This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report code 0049U for the NPM1 MRD by NGS LabPMM LLC, an Invivoscribe Technologies, Inc. Company, which is a next–generation sequencing assay using polymerase chain reaction (PCR) on followup specimens to detect tumor–specific markers of the gene for nucleophosmin, also known as NPM1 for post–treatment monitoring or recurrence for conditions such as acute myeloid leukemia.
For clinical responsibility, terminology, tips and additional info
start codify free trial.